Evidence map›Paper›PMID 41463749›Full record

ArticleAntibiotics (Basel, Switzerland)2025

In Vitro Evaluation of Fosfomycin Combinations Against Metallo-β-Lactamase-Producing

Esther Wohlfarth, Aurélien Dinh, Georgia Vrioni, Dorota Żabicka, Mariano Bernardo, Carlo Tascini, Latifa Noussair, Christian Mayer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Esther WohlfarthAntiinfectives Intelligence GmbH, 51105 Cologne, Germany.ORCID 0000-0001-9756-7385
Aurélien DinhInfectious Disease Department, University Hospital Raymond-Poincaré, 92380 Garches, France.ORCID 0000-0002-5843-4819
Georgia VrioniDepartment of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-4766-8238
Dorota ŻabickaDepartment of Epidemiology and Clinical Microbiology, National Medicines Institute, 00725 Warsaw, Poland.ORCID 0000-0001-9386-8885
Mariano BernardoMicrobiology and Virology Unit, Cotugno Hospital, Azienda Ospedaliera dei Colli, 80131 Naples, Italy.
Carlo TasciniDepartment of Medicine (DMED), Infectious Diseases Clinic, University of Udine, 56100 Udine, Italy.ORCID 0000-0001-9625-6024
Latifa NoussairMicrobiology Department, University Hospital Raymond-Poincaré, 92380 Garches, France.
Christian MayerInfectoPharm Arzneimittel und Consilium GmbH, 64646 Heppenheim, Germany.

Funding

InfectoPharm Arzneimittel und Consilium GmbH (Germany) N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial resistance (AMR)carbapenem resistancecefiderocolceftazidime–avibactamfosfomycinfractional inhibitory concentration (FIC)Klebsiella pneumoniaemetallo-β-lactamase (MBL)multidrug resistance (MDR)Pseudomonas aeruginosasynergy

Identifiers

PMID41463749
PMCPMC12729803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.